Solène Guihéneuf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Solène Guihéneuf has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
D. Floner
2 shared publications- Florence Geneste
Université de Rennes, CNRS, Institut des Sciences Chimiques de Rennes, UMR
2 shared publications - François Carreaux
Université de Rennes, CNRS, ISCR (Institut des Sciences Chimiques de Rennes) UMR 6226, 263 Avenue du Général Leclerc, Campus de Beaulieu, F-35000 Rennes, France
2 shared publications J.-M. Fontmorin
2 shared publications- Jean-Pierre Bazureau
Institut des Sciences Chimiques de Rennes, ISCR UMR 6226, groupe CORINT, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, 263 Av. du Gén. Leclerc, CS 74205, 35042 Rennes Cedex (France)
2 shared publications - Laurent Meijer
Perha Pharmaceuticals, Perharidy Peninsula, 29680 Roscoff, France
2 shared publications
Latest Publications
- 23 November 2023
- Published by Elsevier in Electrochimica Acta
- Vol. 475
Long-cycling of a water-soluble quinizarin derivative in redox flow batteries: Role of the cut-off voltage on the stability
- 23 November 2023
- Published by Elsevier in Electrochimica Acta
- Vol. 475
Long-cycling of a water-soluble quinizarin derivative in redox flow batteries: Role of the cut-off voltage on the stability
- Open Access
- 27 October 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (11) , 1086
Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
Here, we report on the synthesis of libraries of new 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones 3 (twenty-two compounds) and new 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones 5 (twenty-four compounds) with stereo controlled Z-geometry under microwave irradiation. The 46 designed final compounds were tested in order to determine their activity against four representative protein kinases (DYR1A, CK1, CDK5/p25, and GSK3α/β). Among these 1,3-thiazolidin-4-ones, the molecules (5Z) 5-(4-hydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one 3e (IC50 0.028 μM) and (5Z)-5-benzo[1,3]dioxol-5-ylmethylene-2-(pyridin-2-yl)amino-1,3-thiazol-4(5H)-one 5s (IC50 0.033 μM) were identified as lead compounds and as new nanomolar DYRK1A inhibitors. Some of these compounds in the two libraries have been also evaluated for their in vitro inhibition of cell proliferation (Huh7 D12, Caco2, MDA-MB 231, HCT 116, PC3, and NCI-H2 tumor cell lines). These results will enable us to use the 1,3-thiazolidin-4-one core as pharmacophores to develop potent treatment for neurological or oncological disorders in which DYRK1A is fully involved.
- 27 October 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (11) , 1086
Open AccessDesign and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
Here, we report on the synthesis of libraries of new 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones 3 (twenty-two compounds) and new 2-amino-5-arylidene-1,3-thiazol-4(5H)-ones 5 (twenty-four compounds) with stereo controlled Z-geometry under microwave irradiation. The 46 designed final compounds were tested in order to determine their activity against four representative protein kinases (DYR1A, CK1, CDK5/p25, and GSK3α/β). Among these 1,3-thiazolidin-4-ones, the molecules (5Z) 5-(4-hydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one 3e (IC50 0.028 μM) and (5Z)-5-benzo[1,3]dioxol-5-ylmethylene-2-(pyridin-2-yl)amino-1,3-thiazol-4(5H)-one 5s (IC50 0.033 μM) were identified as lead compounds and as new nanomolar DYRK1A inhibitors. Some of these compounds in the two libraries have been also evaluated for their in vitro inhibition of cell proliferation (Huh7 D12, Caco2, MDA-MB 231, HCT 116, PC3, and NCI-H2 tumor cell lines). These results will enable us to use the 1,3-thiazolidin-4-one core as pharmacophores to develop potent treatment for neurological or oncological disorders in which DYRK1A is fully involved.
- Open Access
- 9 June 2021
- Published by Wiley in ChemElectroChem
- Vol. 8 (13) , 2526-2533
Behaviour of 3,4‐Dihydroxy‐9,10‐Anthraquinone‐2‐Sulfonic Acid in Alkaline Medium: Towards a Long‐Cycling Aqueous Organic Redox Flow Battery
The performance of a redox compound in redox flow batteries (RFB) highly depends on the electrolytic medium and operating conditions. It is exemplified in this work with the commercially available and relatively low‐cost dye 3,4‐dihydroxy‐9,10‐anthraquinone‐2‐sulfonic acid (ARS), which was used as negolyte in basic medium. At high pH, the ARS behavior revealed interesting features for RFB applications, such as a low half‐wave potential of −0.99 V (vs Ag/AgCl), negatively shifted by phenolate groups, and an improved solubility compared with acidic medium depending on the nature of the cations. For the highly soluble ARS potassium salt (ARSK), a maximum power density of 117 mW cm−2 and a demonstrated energy density of 20 Wh L−1 were obtained with K4[Fe(CN)6] as posolyte. The capacity slightly decreased during cycling, reaching 90 % after 325 cycles. A long cycling of ARS sodium salt (ARSNa) over 11 operating months was demonstrated in this work. A slow chemical degradation was highlighted giving rise to the formation of 3‐hydroxy‐9,10‐anthraquinone‐2‐sulfonic acid (HAQS) as the main degradation product due to hydrodeoxygenation reaction. Interestingly, this compound exhibited high performance in RFB and a good stability with a loss of capacity of 0.29 % per day.
- 9 June 2021
- Published by Wiley in ChemElectroChem
- Vol. 8 (13) , 2526-2533
Open AccessBehaviour of 3,4‐Dihydroxy‐9,10‐Anthraquinone‐2‐Sulfonic Acid in Alkaline Medium: Towards a Long‐Cycling Aqueous Organic Redox Flow Battery
The performance of a redox compound in redox flow batteries (RFB) highly depends on the electrolytic medium and operating conditions. It is exemplified in this work with the commercially available and relatively low‐cost dye 3,4‐dihydroxy‐9,10‐anthraquinone‐2‐sulfonic acid (ARS), which was used as negolyte in basic medium. At high pH, the ARS behavior revealed interesting features for RFB applications, such as a low half‐wave potential of −0.99 V (vs Ag/AgCl), negatively shifted by phenolate groups, and an improved solubility compared with acidic medium depending on the nature of the cations. For the highly soluble ARS potassium salt (ARSK), a maximum power density of 117 mW cm−2 and a demonstrated energy density of 20 Wh L−1 were obtained with K4[Fe(CN)6] as posolyte. The capacity slightly decreased during cycling, reaching 90 % after 325 cycles. A long cycling of ARS sodium salt (ARSNa) over 11 operating months was demonstrated in this work. A slow chemical degradation was highlighted giving rise to the formation of 3‐hydroxy‐9,10‐anthraquinone‐2‐sulfonic acid (HAQS) as the main degradation product due to hydrodeoxygenation reaction. Interestingly, this compound exhibited high performance in RFB and a good stability with a loss of capacity of 0.29 % per day.
- 6 October 2011
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 10 (5) , 978-987
An efficient approach to dispacamide A and its derivatives
Dispacamide A and new analogs of this marine alkaloid were prepared in seven steps with an overall yield ranging from 12 to 33%. The key step of the strategy was a stereocontrolled Knoevenagel condensation under microwave dielectric heating in the last step. In this condensation, the 2-aminoimidazolin-4-one hydrochloride partners 10a–c were synthesized in three steps with good overall yields (33–79%) via the ring closure of N-guanidino acetic acids 9a–c and the aldehydes 5a,b as the two others building-blocks, in 3 steps with 60–66% overall yields. The six synthetic products have been obtained with a Z geometry about their exocyclic bond on the basis of 13C/1H long-range coupling constants using a gHSQMBC experiment.
- 6 October 2011
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 10 (5) , 978-987
An efficient approach to dispacamide A and its derivatives
Dispacamide A and new analogs of this marine alkaloid were prepared in seven steps with an overall yield ranging from 12 to 33%. The key step of the strategy was a stereocontrolled Knoevenagel condensation under microwave dielectric heating in the last step. In this condensation, the 2-aminoimidazolin-4-one hydrochloride partners 10a–c were synthesized in three steps with good overall yields (33–79%) via the ring closure of N-guanidino acetic acids 9a–c and the aldehydes 5a,b as the two others building-blocks, in 3 steps with 60–66% overall yields. The six synthetic products have been obtained with a Z geometry about their exocyclic bond on the basis of 13C/1H long-range coupling constants using a gHSQMBC experiment.